about
Abiraterone in the treatment of metastatic castration-resistant prostate cancerPhase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patients.Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients.Therapeutic pipeline for soft-tissue sarcoma.Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor.Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacy.Abiraterone acetate for the treatment of prostate cancer.Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer.Multidisciplinary consensus: a practical guide for the integration of abiraterone into clinical practice.Review and analysis of FDA approved drugs using lipid-based formulations.Reply to: Gilligan T. Is there such a thing as cancer treatment that isn't worth its cost? The oncologist 2012;17:3-4.To Take or Not to Take With Meals? Unraveling Issues Related to Food Effects Labeling for Oral Antineoplastic Drugs.The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer.Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration-resistant prostate cancer.Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer.Food Effect on Oral Bioavailability: Old and New Questions.Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects.
P2860
Q26853635-313010B5-76C4-4D6B-ADE4-49ADE2727C7DQ33434141-2691A75A-1836-4801-870D-DC8401F682B3Q33633424-F688032D-98F0-400E-907D-5AAAB0266D2AQ36906428-5363058D-112F-424A-B92B-5D2208DE9C61Q37931268-61FEBD9D-39D6-4F16-8539-39821A1C992AQ37963173-3044480C-24E7-4060-A712-946C1441739FQ38024126-A0A80AC4-83E3-4118-9B7E-3AD31B6E44F2Q38063964-33469E57-1B02-4716-8B5C-7DB24563706BQ38183819-E9DACD56-2853-495A-BF7F-255D3887BCAFQ38240768-63F85AEE-86AA-4230-BD19-6F990A732418Q39411779-7B91E053-9AD6-425D-9065-04F28DA555F4Q43012555-9135C911-67BE-47F0-8864-56713FD4D11DQ49350350-893B1C04-0950-4411-9F57-86177FB0ACA7Q50098388-8DC443A3-3CD0-4DBC-95F7-DB854E28096BQ51301052-53051292-A01E-4A09-A5BB-38D4AA964F5BQ51302682-80D4E962-6B92-47E4-AD15-101CAEFF4D25Q53370868-A8818EED-8690-4320-A428-E988615AF6F8Q55060584-3DF67410-D425-4C7C-BDE4-93783FF63C4F
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Flushing oral oncology drugs down the toilet.
@en
Flushing oral oncology drugs down the toilet.
@nl
type
label
Flushing oral oncology drugs down the toilet.
@en
Flushing oral oncology drugs down the toilet.
@nl
prefLabel
Flushing oral oncology drugs down the toilet.
@en
Flushing oral oncology drugs down the toilet.
@nl
P921
P356
P1476
Flushing oral oncology drugs down the toilet.
@en
P304
P356
10.1200/JCO.2011.37.1617
P407
P577
2011-09-19T00:00:00Z